Table of contents:
Video: Three Muscovites With COVID-19 Recovered After Blood Plasma Transfusion
Three Muscovites with COVID-19 recovered after blood plasma transfusion
According to the vice-mayor of Moscow, Anastasia Rakova, patients who received blood plasma from those who recovered from the coronavirus cope with the disease faster and without serious complications. Two of them were treated at the N.V. Sklifosovsky, another - in the city clinical hospital No. 52.
“Two Muscovites who received donor plasma transfusions were discharged from hospitals 10 days after the procedures, the third patient was discharged 14 days later. All of them are now in good condition. We hope that the number of such recovered people will continue to grow and this method of treatment will help us cope with the coronavirus pandemic,”Rakova said.
Last week, Moscow authorities asked people who have recovered from COVID-19 to donate their blood plasma to help patients who are struggling with the disease right now. The purpose of this method is to transfer antibodies from the blood of a recovered person to a patient in the acute phase of the disease. To date, 60 Muscovites have donated their plasma. Now this method of treatment is going to be applied in other regions too - the authorities of Vologda, Penza and Tatarstan have made similar appeals to the people.
A blood plasma donor can be a person aged 18 to 55, who has had coronavirus and does not have chronic diseases, with a negative test for HIV, hepatitis B and C. Blood donors with antibodies to COVID-19 will receive incentive payments: 1250 rubles for 150 milliliters of plasma, and for 600 milliliters of plasma - 5000 rubles.
The plasma donation hotline is open daily from 9:00 to 19:00 by phone 8 (495) 870-45-16.
Popular by topic
What gives the body quitting smoking
The surface of the wounds was significantly reduced compared to the effect of the standard method of treatment
Scientists suggest older people may need additional vaccinations
Current guidelines do not require blood tests for SARS-CoV-2 in such donors
The vaccine successfully stimulated the production of antibodies and T cells, the scientists did not find any serious side effects